Plum SEC
  • Korean Market
  • Community
  • Contact Us

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
EXCH
Hanmi Pharm
★
Hanmi Pharm Signs Supply Contract for 3 Cardiovascular/Respiratory Drugs in Philippines and Malaysia (Approx. 52.7 Billion KRW)
 12h ago
PERI
Hanmi Pharm
★★★
Hanmi Pharmaceutical Reports Improved Q1 2026 Results, R&D Progress, and Shareholder Return Policy
 05/15/2026, 04:32 PM
OWNR
Hanmi Pharm
★
NPS Submits Report on Ownership of Specified Securities
 05/10/2026, 07:00 PM
EXCH
Hanmi Pharm
★
Hanmi Pharm 1Q26 OP -9.1% YoY, NP +14.4%
 05/03/2026, 07:00 AM
EXCH
Hanmi Pharm
★
2026 Q1 Business Overview Presentation via Meritz Securities NDR
 05/03/2026, 07:00 AM
EXCH
Hanmi Pharm
★
Notice of Investor Relations Event - Participation in Korea Investment & Securities NDR
 05/03/2026, 07:00 AM
OTHR
Hanmi Pharm
★
Hanmi Pharm Confirms Appointment of Outside Director Chae Yi-bae (Term starts Apr 29)
 05/03/2026, 07:00 AM
  • «
  • 1
  • »
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.